322 related articles for article (PubMed ID: 16447040)
1. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes.
Morohara K; Tajima Y; Nakao K; Nishino N; Aoki S; Kato M; Sakamoto M; Yamazaki K; Kaetsu T; Suzuki S; Tsunoda A; Tachikawa T; Kusano M
J Cancer Res Clin Oncol; 2006 Jun; 132(6):363-75. PubMed ID: 16447040
[TBL] [Abstract][Full Text] [Related]
2. Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations.
Yamazaki K; Tajima Y; Makino R; Nishino N; Aoki S; Kato M; Sakamoto M; Morohara K; Kaetsu T; Kusano M
World J Gastroenterol; 2006 Jun; 12(24):3803-9. PubMed ID: 16804962
[TBL] [Abstract][Full Text] [Related]
3. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background.
Tajima Y; Yamazaki K; Makino R; Nishino N; Aoki S; Kato M; Morohara K; Kaetsu T; Kusano M
Clin Cancer Res; 2006 Nov; 12(21):6469-79. PubMed ID: 17085661
[TBL] [Abstract][Full Text] [Related]
4. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains.
Shiroshita H; Watanabe H; Ajioka Y; Watanabe G; Nishikura K; Kitano S
Pathol Int; 2004 May; 54(5):311-21. PubMed ID: 15086835
[TBL] [Abstract][Full Text] [Related]
5. Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions.
Tajima Y; Yamazaki K; Nishino N; Morohara K; Yamazaki T; Kaetsu T; Suzuki S; Kawamura M; Kumagai K; Kusano M
Br J Cancer; 2004 Oct; 91(7):1342-8. PubMed ID: 15354218
[TBL] [Abstract][Full Text] [Related]
6. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions.
Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
Oncology; 2001; 61(3):212-20. PubMed ID: 11574777
[TBL] [Abstract][Full Text] [Related]
7. Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil.
Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
J Cancer Res Clin Oncol; 2003 Dec; 129(12):683-90. PubMed ID: 14576935
[TBL] [Abstract][Full Text] [Related]
8. Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach.
Tajima Y; Yamazaki K; Makino R; Nishino N; Masuda Y; Aoki S; Kato M; Morohara K; Kusano M
Br J Cancer; 2007 Feb; 96(4):631-8. PubMed ID: 17262083
[TBL] [Abstract][Full Text] [Related]
9. Relationship between biological behavior and phenotypic expression in undifferentiated-type gastric carcinomas.
Kabashima A; Yao T; Maehara Y; Tsuneyoshi M
Gastric Cancer; 2005; 8(4):220-7. PubMed ID: 16328596
[TBL] [Abstract][Full Text] [Related]
10. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
[TBL] [Abstract][Full Text] [Related]
11. Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.
Silva EM; Begnami MD; Fregnani JH; Pelosof AG; Zitron C; Montagnini AL; Soares FA
Gastric Cancer; 2008; 11(3):149-59. PubMed ID: 18825309
[TBL] [Abstract][Full Text] [Related]
12. Phenotype analysis by MUC2, MUC5AC, MUC6, and CD10 expression in Epstein-Barr virus-associated gastric carcinoma.
Barua RR; Uozaki H; Chong JM; Ushiku T; Hino R; Chang MS; Nagai H; Fukayama M
J Gastroenterol; 2006 Aug; 41(8):733-9. PubMed ID: 16988760
[TBL] [Abstract][Full Text] [Related]
13. Gastric and intestinal phenotypes of gastric carcinoma with reference to expression of brain (fetal)-type glycogen phosphorylase.
Shimada S; Matsuzaki H; Marutsuka T; Shiomori K; Ogawa M
J Gastroenterol; 2001 Jul; 36(7):457-64. PubMed ID: 11480789
[TBL] [Abstract][Full Text] [Related]
14. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
[TBL] [Abstract][Full Text] [Related]
15. The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters.
Oz Puyan F; Can N; Ozyilmaz F; Usta U; Sut N; Tastekin E; Altaner S
J Cancer Res Clin Oncol; 2011 Dec; 137(12):1749-62. PubMed ID: 21909647
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer.
Wakatsuki K; Yamada Y; Narikiyo M; Ueno M; Takayama T; Tamaki H; Miki K; Matsumoto S; Enomoto K; Yokotani T; Nakajima Y
J Surg Oncol; 2008 Aug; 98(2):124-9. PubMed ID: 18521835
[TBL] [Abstract][Full Text] [Related]
17. Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach.
Shiratsu K; Higuchi K; Nakayama J
Cancer Sci; 2014 Jan; 105(1):126-33. PubMed ID: 24138592
[TBL] [Abstract][Full Text] [Related]
18. Mucin and differentiation in Epstein-Barr virus-associated gastric carcinoma.
Nakamura Y; Yanai H; Kitou T; Matsubara Y; Hirano A; Okamoto T; Yoshida T; Okita K; Matsusaki K
Hepatogastroenterology; 2005; 52(64):1066-70. PubMed ID: 16001631
[TBL] [Abstract][Full Text] [Related]
19. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.
Pinto-de-Sousa J; David L; Reis CA; Gomes R; Silva L; Pimenta A
Virchows Arch; 2002 Mar; 440(3):304-10. PubMed ID: 11889602
[TBL] [Abstract][Full Text] [Related]
20. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma.
Nakamura T; Yao T; Kabashima A; Nishiyama K; Maehara Y; Tsuneyoshi M
Histopathology; 2005 Oct; 47(4):357-67. PubMed ID: 16178890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
